Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
People With Early Metabolic Syndrome or Insulin Resistance Though still under investigation, early research suggests 5-Amino-1MQ may benefit those with pre-diabetes or insulin resistance by enhancing glucose utilization and reducing visceral fat but clinical supervision is essential
Our formula of Lipotropics has been formulated and perfected by our panel of physicians
Flowchart on Selection of Articles Grading of level of evidence and strength of recommendation was based on strength of recommendation taxonomy (SORT) framework (1
Subcutaneous injection (into fat tissue) is commonly used for amounts less than 0.5 mL
What's happening
The good news is that AOD9604 is an FDA-approved drug as an anti-obesity drug, so you dont have to worry about adverse effects at all
